dorsaVi Ltd (ASX:DVL)

CTI BioPharma Statistics

Total Valuation

dorsaVi has a market cap or net worth of AUD 28.25 million. The enterprise value is 27.14 million.

Market Cap	28.25M
Enterprise Value	27.14M

Important Dates

The last earnings date was Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

dorsaVi has 911.20 million shares outstanding. The number of shares has increased by 10.57% in one year.

Current Share Class	911.20M
Shares Outstanding	911.20M
Shares Change (YoY)	+10.57%
Shares Change (QoQ)	+27.28%
Owned by Insiders (%)	32.54%
Owned by Institutions (%)	1.31%
Float	445.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.98
PB Ratio	16.82
P/TBV Ratio	17.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.80
EV / Sales	20.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.85

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.08.

Current Ratio	2.86
Quick Ratio	2.17
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-141.57

Financial Efficiency

Return on equity (ROE) is -74.01% and return on invested capital (ROIC) is -56.92%.

Return on Equity (ROE)	-74.01%
Return on Assets (ROA)	-37.82%
Return on Invested Capital (ROIC)	-56.92%
Return on Capital Employed (ROCE)	-86.52%
Revenue Per Employee	39,591
Profits Per Employee	-33,531
Employee Count	34
Asset Turnover	0.53
Inventory Turnover	0.20

Taxes

Income Tax	-389,598
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +158.33% in the last 52 weeks. The beta is 0.28, so dorsaVi's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+158.33%
50-Day Moving Average	0.02
200-Day Moving Average	0.01
Relative Strength Index (RSI)	73.68
Average Volume (20 Days)	6,205,382

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, dorsaVi had revenue of AUD 1.35 million and -1.14 million in losses. Loss per share was -0.00.

Revenue	1.35M
Gross Profit	1.24M
Operating Income	-1.53M
Pretax Income	-1.53M
Net Income	-1.14M
EBITDA	-1.50M
EBIT	-1.53M
Loss Per Share	-0.00

Balance Sheet

The company has 1.24 million in cash and 131,482 in debt, giving a net cash position of 1.11 million or 0.00 per share.

Cash & Cash Equivalents	1.24M
Total Debt	131,482
Net Cash	1.11M
Net Cash Per Share	0.00
Equity (Book Value)	1.68M
Book Value Per Share	0.00
Working Capital	1.57M

Cash Flow

In the last 12 months, operating cash flow was -714,944 and capital expenditures -1,979, giving a free cash flow of -716,923.

Operating Cash Flow	-714,944
Capital Expenditures	-1,979
Free Cash Flow	-716,923
FCF Per Share	-0.00

Margins

Gross margin is 92.27%, with operating and profit margins of -114.01% and -84.69%.

Gross Margin	92.27%
Operating Margin	-114.01%
Pretax Margin	-113.64%
Profit Margin	-84.69%
EBITDA Margin	-111.31%
EBIT Margin	-114.01%
FCF Margin	n/a

Dividends & Yields

dorsaVi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.57%
Shareholder Yield	-10.57%
Earnings Yield	-4.04%
FCF Yield	-2.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

dorsaVi has an Altman Z-Score of -20.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.75
Piotroski F-Score	3